End of Day, Cause and Effect Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
MEDS.PK together with its Russian licensee, ERCell LLC, successfully dosed 3 heart failure patients Read more…
KOOL has implemented a number of changes in corporate management responsibilities Read more…
MSB.AX’s off-the-shelf, allogeneic, Mesenchymal Precursor Cell (MPC) product for Type 2 diabetes … Read more…
Good morning! Here’s what you … might need to know to start the day. Read more…
End of Day, Cause and Effect Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
Juventas Therapeutics is a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease. Read more…
STEM announced the publication of preclinical data … Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.